Literature DB >> 6553601

Incidence of distal intestinal obstruction syndrome in cystic fibrosis.

B J Rosenstein, T S Langbaum.   

Abstract

A variety of intestinal complications, including constipation, abdominal pain, palpable cecal masses, intestinal obstruction, intussusception, and volvulus, have been observed beyond the neonatal period in patients with cystic fibrosis (CF). In a retrospective chart review of 63 patients with CF, we found evidence of one or more of these complications in 26 patients (41.3%). The incidence of intestinal complications was not related to overall disease severity, pulmonary exacerbations, history of meconium ileus at birth, or dose or type of pancreatic enzyme replacement. There was no change in the incidence of intestinal complications after patients switched to a pH-sensitive enteric-coated microsphere enzyme preparation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6553601

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  11 in total

Review 1.  A rational approach to the nutritional care of patients with cystic fibrosis.

Authors:  P R Durie; P B Pencharz
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 2.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

3.  Pathology mimicking distal intestinal obstruction syndrome in cystic fibrosis.

Authors:  A M Dalzell; D P Heaf; H Carty
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

4.  Pitfalls in the diagnosis of appendix abscess in cystic fibrosis.

Authors:  H L Smith; P H Weller; P Gornall; S Chapman; T J Jones
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

5.  Clinical features, pathogenesis and management of meconium ileus equivalent.

Authors:  P H Weller; J Williams
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 6.  Abdominal pain in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

7.  Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.

Authors:  Scott M Blackman; Rebecca Deering-Brose; Rita McWilliams; Kathleen Naughton; Barbara Coleman; Teresa Lai; Marilyn Algire; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; M Daniele Fallin; Kristen West; Dan E Arking; Aravinda Chakravarti; David J Cutler; Garry R Cutting
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

Review 8.  Fibrosing colonopathy in cystic fibrosis.

Authors:  R L Smyth
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

9.  Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Authors:  Moran Lavie; Tzipora Manovitz; Daphna Vilozni; Sarina Levy-Mendelovich; Ifat Sarouk; Ilana Weintraubv; David Shoseyov; Malena Cohen-Cymberknoh; Joseph Rivlin; Ori Efrati
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

10.  Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation.

Authors:  Jonathan R Morton; Nabila Ansari; Allan R Glanville; Alan P Meagher; Reginald V N Lord
Journal:  J Gastrointest Surg       Date:  2009-05-22       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.